Village Farms International, Inc.: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Nov 13, 2020 and accepted by EDGAR at Nov 13, 2020, 07:00 ET.
Management's discussion and analysis
As filed, 56,885 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated interim financial statements and related notes included in Item 1 of Part I of this Quarterly Report and the Management’s Discussion and Analysis of Financial Condition and Results of Operations and consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 31, 2019. The September 30, 2019 figures are based on the Company’s recently restated U.S. Generally Accepted Accounting Principles (“GAAP”) results filed on Form 8-K on April 22, 2020 and not the Company’s financial statements, prepared in accordance with International Accounting Standard 34 – Interim Financial Reporting as issued by the International Accounting Standards Board, filed in August 2019. This discussion and analysis contain forward-looking statements about our plans and expectations of what may happen in the future. Forward-looking statements are based on a number of assumptions and estimates that are inherently subject to significant risks and uncertainties, and our actual results could differ materially from the results anticipated by our forward-looking statements, particularly in light of the ongoing and developing COVID-19 pandemic. See “Forward-Looking Statements”.
EXECUTIVE OVERVIEW
Through our subsidiary, the British Columbia-based Pure Sunfarms Corp. (“PSF” or “Pure Sunfarms”), we have one of the single largest cannabis growing operations in the world. On November 2, 2020, we completed the acquisition of the remaining 41.3% interest in Pure Sunfarms from Emerald Health Therapeutics, Inc. (“Emerald”), following which we became the 100% owner of Pure Sunfarms (the “Pure Sunfarms Transaction”). See “Acquisition of Remaining Interest in Pure Sunfarms” below. We are also one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Further, we have joint venture operations in hemp and high cannabidiol (“CBD”) products and investments in cannabis opportunities in Asia and Holland.
Pure Sunfarms has leveraged our 30 years of experience as a vertically integrated greenhouse produce grower for the rapidly emerging cannabis opportunity following legalization of cannabis in Canada. Pure Sunfarms is currently one of the largest producers of cannabis in Canada with distribution in five of the six largest provinces. Its long-term objective is to be the leading low cost, high quality cannabis producer in Canada and internationally.
In our produce greenhouse operations, we produce, market and sell fresh, premium-quality produce with consistency 365 days a year to national grocers in the United States (“U.S.”) and Canada from more than eight million square feet of Controlled Environment Agriculture (“CEA”) greenhouses in British Columbia (“B.C.”) and Texas, as well as from our partner greenhouses in B.C., Ontario and Mexico.
We are pursuing opportunities to become a vertically integrated leader in the U.S. hemp-derived CBD market, subject to compliance with all applicable U.S. federal and state laws and will pursue controlled environment hemp production at one of our Texas greenhouse operations, once the current CBD regulatory environment becomes clearer due to the restrictive rulings of the Food and Drug Administration, U.S. Department of Agriculture and U.S. Drug Enforcement Administration. Our U.S. multi-state outdoor cultivation business is operated through our 65% interest in Village Fields Hemp USA, LLC (“VF Hemp” or “VFH”) in multiple states throughout the United States.
Our subsidiary VF Clean Energy, Inc. (“VFCE”), owns and operates a 7.0 MW power plant that generates electricity. On November 10, 2020 we announced we will be transitioning this operation to a Renewable Natural Gas (“RNG”) operation in conjunction with Mas Energy, LLC which will enhance our financial return as well as provide food-grade CO2 , which can be used in both our cannabis and produce growing operations in Delta, B.C.
In the third quarter of 2020, the Company acquired minority interests in two international companies, DutchCanGrow (“DCG”) in the Netherlands and Asia-based Altum International Pty Ltd (“Altum”), in order to leverage our experience and expand into international cannabis and CBD opportunities.
Acquisition of Remaining Interest in Pure Sunfarms
On September 8, 2020, we entered into a purchase agreement (the “Purchase Agreement”) with Emerald to purchase from Emerald 36,958,500 common shares in the capital of Pure Sunfarms, representing 41.3% of the issued and outstanding common shares of Pure Sunfarms and all of the remaining common shares of Pure Sunfarms not held by the Company. On November 2, 2020, we consummated the Pure Sunfarms Transaction for a total aggregate purchase price of C$79.9 million (US$60.0 million), satisfied through a C$60.0 million (US $45.0 million) cash payment and a C$19.9 million (US$14.5 million) secured promissory note payable to Emerald due on May 2, 2021 (the “Promissory Note”). Interest on the principal amount owed under the Promissory Note will accrue at the lower of (i) the maximum non-usurious rate of interest under applicable law or (ii) 12% per annum. In order to secure our obligations under the Promissory Note, on November 2, 2020, we entered into a share pledge agreement (the “Share Pledge Agreement”) with Emerald and Computershare Trust Company of Canada, as collateral agent, in order to pledge 9,239,625 common shares of Pure Sunfarms to Emerald as collateral for the amounts owed by us under the Promissory Note. Also, on November 2, 2020, in connection with the consummation of the Pure Sunfarms Transaction, the Company and Emerald terminated the shareholders agreement, dated as of June 6, 2017, by and between the Company and Emerald, which had governed the business and affairs of Pure Sunfarms.
The Purchase Agreement contains representations and warranties customary for transactions of this nature negotiated between sophisticated purchasers and sellers acting at arm’s length, certain of which are qualified as to materiality and knowledge and subject to reasonable exceptions. Subject to certain exceptions, the representations and warranties of the Company and Emerald in the Purchase Agreement will survive for a period of 18 months from the closing date of the Pure Sunfarms Transaction. Certain “fundamental” representations, however, will survive the closing of the Pure Sunfarms Transaction for a period of six years.
Pursuant to the Purchase Agreement, each of the Company and Emerald have agreed, following closing, to indemnify the other party and its affiliates against any loss arising from a breach of a representation, warranty, or covenant given by the Company or Emerald, respectively, under the Purchase Agreement. The indemnity is subject to certain limitations, including that neither the Company nor Emerald are required to indemnify the other party unless and until losses exceed C$500,000, at which point Village Farms or Emerald, as the case may be, will be entitled to recover the full amount of such losses from the first dollar. The indemnity is also capped at 100% of the purchase price under the Purchase Agreement and no party is liable for any losses resulting from any breach of any representation or warranty in the Purchase Agreement if the party seeking indemnification knew about the inaccuracy or breach before closing.
In addition, the Company and Emerald entered into a non-solicitation agreement on the closing date of the Pure Sunfarms Transaction pursuant to which Emerald has agreed not to solicit or hire any employees of Pure Sunfarms or the Company for a period of three years following the closing date, subject to customary exceptions.
Registered Direct Offering
On September 10, 2020, we completed a registered direct offering (the “Registered Direct Offering”) of 9,396,226 units (each, a “Unit”), with each Unit consisting of one common share in the capital stock of the Company (each, a “Common Share”) and 0.50 of a warrant to purchase one Common Share (each, a “Warrant”). Each Unit was sold at a public offering price of $5.30 per Unit. The Warrants included in the Units will initially be exercisable on March 10, 2021, at an exercise price of $5.80 per share, subject to adjustment in certain circumstances, and will expire five years from the date of issuance (subject to the call right provided for in the Warrants).
The net proceeds to the Company after deducting placement agent fees were approximately $46.8 million, excluding the proceeds, if any, from the exercise of the Warrants, and prior to deducting estimated offering expenses payable by the Company. We used approximately $37.5 million of the net proceeds from the Registered Direct Offering to finance the Pure Sunfarms Transaction.
Recent developments relating to the outbreak of the Coronavirus pandemic (“COVID-19”)
In March 2020, the World Health Organization declared the outbreak of the COVID-19 virus a global pandemic. This outbreak continues to cause major disruptions to businesses and markets worldwide as the virus continues to spread. A number of countries as well as certain states and cities within the United States and Canada have enacted temporary closures of businesses, issued quarantine or shelter-in-place orders and taken other restrictive measures in response to COVID-19.
To date, all of our operations are operating normally, however, the extent to which COVID-19 and the related global economic crisis affect our business, results of operations and financial condition, will depend on future developments that are highly uncertain and cannot be predicted, including the scope and duration of the pandemic and any recovery period, future actions taken by governmental authorities, central banks and other third parties (including new financial regulation and other regulatory reform) in response to the pandemic, and the effects on our produce, clients, vendors and employees. We continue to service our customers amid uncertainty and disruption linked to COVID-19 and we are actively managing our business to respond to the impact.
RESULTS OF OPERATIONS
(In thousands of U.S. dollars, except share and per share amounts, and unless otherwise noted)
Consolidated Financial Performance
| For the three months ended September 30, 2020 | 2019 | For the nine months ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Sales | $43,037 | $38,293 | $122,722 | $111,512 |
| Cost of sales | (37,418) | (38,904) | (112,809) | (114,418) |
| Gross margin | 5,619 | (611) | 9,913 | (2,906) |
| Selling, general and administrative expenses | (4,942) | (3,739) | (12,676) | (11,899) |
| Stock compensation expense | (472) | (666) | (1,329) | (2,663) |
| Interest expense | (299) | (655) | (1,273) | (2,018) |
| Interest income | 101 | 304 | 577 | 651 |
| Foreign exchange (loss) gain | (484) | (183) | (880) | 338 |
| Gain on settlement agreement | — | — | 4,681 | — |
| Other income, net | 27 | 69 | 92 | 219 |
| (Loss) gain on disposal of assets | — | (8) | (6) | 13,558 |
| (Provision for) recovery of income taxes | (336) | 1,266 | 607 | 114 |
| Net Loss from consolidated entities after income taxes | (786) | (4,223) | (294) | (4,606) |
| Equity earnings of unconsolidated entities | 1,306 | 3,519 | 4,885 | 14,115 |
| Net income (loss) | $520 | $(704) | $4,591 | $9,509 |
| Adjusted EBITDA (1) | $4,556 | $2,881 | $7,921 | $8,326 |
| Earnings (loss) per share - basic | $0.01 | $(0.01) | $0.08 | $0.20 |
| Earnings (loss) per share – diluted | $0.01 | $(0.01) | $0.08 | $0.19 |
(1) Adjusted earnings before interest expense, income tax, depreciation and amortization (“EBITDA”) is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. See “Non-GAAP Measures” for a definition and reconciliation of Adjusted EBITDA to net income, the nearest comparable measurement under GAAP. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company. For the periods presented, Adjusted EBITDA includes the Company’s majority non-controlling interest in Pure Sunfarms and 65% interest in VFH.
JV Cannabis Business – Pure Sunfarms (USD)
Set forth below are the operating results of Pure Sunfarms, before any allocation to Village Farms, which are not consolidated in our financial results for the three and nine months ended September 30, 2020 and 2019 in accordance with GAAP. Subsequent to September 30, 2020, we completed the Pure Sunfarms Transaction, and we will consolidate Pure Sunfarms in our operating results for future periods. A discussion of our consolidated results for the three and nine months ended September 30, 2020 and 2019, including our Produce Segment, is included further below.
Three months ended September 30, 2020 compared to the three months ended June 30, 2020.
Sales
Sales for three months ended September 30, 2020 increased to $17,048 as compared to $9,386, or an 81% quarter on quarter increase from the three months ended June 30, 2020. The increase was primarily driven by a 148% increase in sales in the wholesale channel, a 22% quarter on quarter increase in sales to provincial (retail) boards and the September launch of Pure Sunfarms Cannabis 2.0 derivative products, which includes cannabis oil and vape pens. The quarter on quarter growth in retail sales is directly attributable to a 165.7% increase in Pure Sunfarms retail small format, a 29.7% quarter on quarter increase in pre-rolls and a (42.7%) decrease in Pure Sunfarms retail large format as the large format was launched in the second quarter of 2020 and the third quarter retail large format sales consisted of ongoing reorder sales.
The channel makeup of the third quarter sales was 54% to the retail channel and 46% to the wholesale channel. The channel makeup of the second quarter sales was 69% to the retail channel and 31% to the wholesale channel. Cannabis 2.0 derivative products were 4.4% of third quarter sales.
The net average selling price for the three months ended September 30, 2020 was higher than the net average selling price for the three months ended June 30, 2020 by 17.4%, due to an increase in small format retail sales versus large format retail sales, a quarter on quarter increase in sales price of retail flower SKUs and a slight increase in wholesale pricing, which is impacted by the makeup of the potency of flower biomass sold to various wholesale customers.
Cost of Sales
Cost of sales for the three months ended September 30, 2020 and three months ended June 30, 2020 was $11,154 and $6,266, respectively, an increase of 78%. The third quarter of 2020 cost of sales includes an inventory write down of $1,042 for distillate inventory purchased from third party extraction companies for which the market value had dropped since the initial purchase. The quarter on quarter increase in costs, excluding the distillate inventory write down is 61.4%, was due to a 143% increase in wholesale kilograms sold, a 120% increase in retail small format kilograms sold which has higher overhead and labor cost compared to retail large format, and the launch of recently approved Cannabis 2.0 derivative products which are co-manufactured by another licensed producer.
Gross Margin
Gross margin for the three months ended September 30, 2020 and three months ended June 30, 2020 was 34.6% and 33.2%, respectively, excluding the distillate inventory write down, the gross margin was 40.7%, The quarter on quarter improvement was due to an increase in wholesale sell price and an increase in small format retail flower sales as compared to higher sales of Pure Sunfarms retail large format products in the second quarter of 2020, which have a lower gross margin.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the three months ended September 30, 2020 and three months ended June 30, 2020 were $2,447 and $1,850, respectively, an increase of 32.3%. The increase was primarily due to investments in retail sales, marketing, and staffing.
Net Income
Net income for the three months ended September 30, 2020 and three months ended June 30, 2020 was $2,457 and $790 respectively, an increase of 211%. The increase was primarily due to the increase in gross margin.
Adjusted EBITDA
Adjusted EBITDA for the three months ended September 30, 2020 increase 133.2% to $4,277 from $1,835 for the second quarter. The third quarter Adjusted EBITDA figure does include the third party distillate inventory write down of $1,042.
Three months ended September 30, 2020 compared to the three months ended September 30, 2019.
Sales
Sales for the three months ended September 30, 2020 and 2019 was $17,048 and $18,084, respectively, a decrease of (5.7%). The change was due to a 362% increase in provincial (retail) sales and a (51.6%) decrease in wholesale selling price for the three months ended September 30, 2020 compared to the three months ended September 30, 2019. The net average selling price for the three months ended September 30, 2020 was lower than the net average selling price for the three months ended September 30, 2019 by (35.8%).
During the three months ended September 30, 2020, approximately 4.4% of the sales were from its recently launched Cannabis 2.0 derivative products, which includes cannabis oil and vape pens, 49.6% of dried flower sales to provincial (retail) boards, with the remaining 46% through the wholesale channel, including nonmonetary transactions with extraction licensed producers in which Pure Sunfarms sold extraction grade dried flower and trim and purchased various forms of distillate from the same counterparties. Pure Sunfarms will use the distillate in future Cannabis 2.0 products.
Cost of Sales
Cost of sales for the three months ended September 30, 2020 and 2019 was $11,154 and $5,689, respectively, an increase of 96.1%. The third quarter 2020 cost of sales includes an inventory write down of ($1,042) for distillate inventory purchased from third party extraction companies for which the market value has dropped since the initial purchase. The year on year increase in costs, excluding the distillate inventory write down was 77.7%, was due to 553% increase in retail kilograms sold which require incremental packaging, overhead and logistics expenses compared to product sold through the wholesale channel, as well as higher depreciation expense charge (a year on year increase of 91%) due to higher volumes.
Gross Margin
Gross margin for the three months ended September 30, 2020 and 2019 was 34.6% and 68.5%, respectively. The decline was due to the $1,042 inventory write down for distillate inventory, in 2020, a lower price environment for the wholesale channel in 2020 as compared to the third quarter of 2019, as well as an increase in costs as a result of Pure Sunfarms’ increase in provincial retail sales in 2020, as the majority of sales in the third quarter of 2019 were made through the wholesale channel.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the three months ended September 30, 2020 and 2019 were $2,447 and $2,830, respectively, a decrease of 13.5%. The decrease was primarily due to wage subsidies received from the Government of Canada as a result of the federal COVID-19 program, without the subsidy the year on year selling, general and administrative expenses were essentially flat.
Net Income
Net income for the three months ended September 30, 2020 and 2019 was $2,457 and $6,685 respectively, a decrease of (63.2%). The decrease was primarily due to the decrease in gross margin.
Adjusted EBITDA
Adjusted EBITDA for the three months ended September 30, 2020 declined (57.5%) to $4,277 from $10,075 for the same prior year period. The decrease was primarily due to the decrease in gross margin.
Nine months ended September 30, 2020 compared to the nine months ended September 30, 2019.
Sales
Sales for the nine months ended September 30, 2020 and 2019 was $39,571 and $53,128, respectively, a decrease of (25.5%). The decrease was due to a lower average selling price for the nine months ended September 30, 2020, compared to 2019, when 95% of Pure Sunfarms’ sales were being made through its wholesale channel during a period of elevated wholesale market pricing. For the nine months ended September 30, 2020, 54.4% of dried flower sales were to provincial (retail) boards, with the remaining 45.6% of sales through the wholesale channel, including nonmonetary transactions with extraction licensed producers in which Pure Sunfarms sold extraction grade dried flower and trim and purchased various forms of distillate from the same counterparties. Pure Sunfarms will use the distillate in future Cannabis 2.0 products.
Net sales for nine months ended September 30, 2020 as compared to net sales for the nine months ended September 30, 2019 were impacted by lower retail pricing, partially due to the introduction of retail large format products, in the second quarter of 2020 as well as lower pricing on both pre-rolls and small format dried flower, in 2020.
Cost of Sales
Cost of sales for the nine months ended September 30, 2020 and 2019 was $23,678 and $13,463, respectively, an increase of 75.9%. The increase was primarily due to an increase in kgs sold of 59.5% and a transition to higher costing provincial (retail) sales products which require incremental packaging and logistics expenses compared to products sold through the wholesale market, as well as higher year on year depreciation expense as a result of higher kgs sold.
Gross Margin
Gross margin percentage for the nine months ended September 30, 2020 was 40.2% and 74.7%, respectively. The decline was due to a lower price environment in 2020, partly driven by the market place acceptance of the larger format SKUs, as well as the increase in cost of sales resulting from Pure Sunfarms’ change in product mix to retail sales in 2020, as the majority of sales for the nine months ended September 30, 2019 were made through the wholesale channel.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the nine months ended September 30, 2020 and 2019 was $6,731 and $5,616, respectively, an increase of 19.9%. The increase was primarily due to higher Health Canada regulatory fees, which are based on provincial kgs sold, as well as incremental year over year expenses for marketing and staffing as a direct result of the provincial (retail) sales in 2020, as Pure Sunfarms did not have its provincial (retail) sales license for the first eight months of 2019.
Other Income, Net
Other income, net for the nine months ended September 30, 2020 and 2019 was $4,201 and $22, respectively. During the first quarter of 2020, Pure Sunfarms recognized a $4,348 gain on settlement of net liabilities resulting from the March 2, 2020 Settlement Agreement between Pure Sunfarms, Emerald Health and Village Farms. This gain is derived from Pure Sunfarms’ forgiveness of Emerald’s shareholder loan, including accrued interest, offset by the extinguishment of the Supply Agreement and a $457 receivable due from Emerald for sales made in the first quarter of 2020 and $5.4 million for sales made in 2019.
Net Income
Net income for the nine months ended September 30, 2020 and 2019 was $9,412 and $24,106, respectively, a decrease of (61.0%). The decrease was primarily due to the decrease in gross margin.
Adjusted EBITDA
Adjusted EBITDA, which excludes the gain on settlement of net liabilities and includes the distillate inventory write down of $1,042, was $10,980 for the nine months ended September 30, 2020, a (69.0%) decrease from $35,419 for the nine months ended September 30, 2019. The decrease was primarily due to a lower grow margin and an increase in selling, general and administrative expenses for the nine months ended September 30, 2020 compared to the same prior year period.
Consolidated Line Item Results
Three months ended September 30, 2020 compared to the three months ended September 30, 2019.
Sales
Produce sales for the three months ended September 30, 2020 increased $4,744, or 12.4%, to $43,037 compared to $38,293 for the three months ended September 30, 2019. The improvement in sales is due to an increase in pricing for tomatoes during the three months ended September 30, 2020 compared to the same prior year period. The average net selling price for total tomato pounds sold increased 30% for the three months ended September 30, 2020 compared to the three months ended September 30, 2019, generated primarily from our commodity items, which includes beefsteak tomatoes and tomatoes on the vine (“TOVs”). The increase in net selling price in the commodity items was primarily the result of a supply shortage throughout most of 2020, due to an increase in grocery store traffic, driven by COVID-19 measures, as well as a global tomato virus that is negatively impacting tomato supplies. Pepper prices increased 19% and pepper pounds sold increased 47% when compared to the same prior year period, due to an increase in our third-party pepper contracts. Cucumber prices increased 1% and cucumber pieces sold decreased (12%) for the three months ended September 30, 2020 as compared to the three months ended September 30, 2019.
Cost of Sales
Cost of sales for the three months ended September 30, 2020 decreased ($1,486), or (3.8%), to $37,418 from $38,904 for the three months ended September 30, 2019, as the Company produced less tomatoes at its facilities in the third quarter of 2020 compared to the same period in 2019 due to the transition of the Delta 2 facility, which converted from tomato production in 2019 to cannabis production for Pure Sunfarms in 2020.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the three months ended September 30, 2020 increased $1,203, or 32.2%, to $4,942 from $3,739 for the three months ended September 30, 2019 driven by incremental legal, acquisition and regulatory expenses related primarily to the Pure Sunfarms negotiations and acquisition and year over year incremental public company filings, and an increase in employee compensation.
Share-based Compensation
Share-based compensation expense for the three months ended September 30, 2020 was $472 compared to $666 for the three months ended September 30, 2019. The decrease in share-based compensation expense is primarily due to the vesting of performance shares earned related to developments in Pure Sunfarms in 2019. Due to the closing of the Pure Sunfarms acquisition in November 2020, there will be incremental share-based compensation expense in the fourth quarter of 2020 due the vesting of performance shares earned relating to the acquisition of Pure Sunfarms and its management team.
Interest Expense
Interest expense for the three months ended September 30, 2020 decreased ($356) to $299 from $655 for the three months ended September 30, 2019. The decrease is primarily due to lower interest rates as well as lower debt balances.
Interest Income
Interest income for the three months ended September 30, 2020 and 2019 was $101 and $304, respectively. We are no longer accruing interest associated with the VF Hemp Grid Loan Agreement.
Income Tax (Provision) Recovery
For the three months ended September 30, 2020, we recorded an income tax provision of ($336) compared to an income tax recovery of $1,266 for the three months ended September 30, 2019. The difference is primarily due to a higher gross margin in the 2020 period. Pure Sunfarms and VF Hemp are both reported post-tax and therefore do not factor into the Company’s tax calculation.
Equity Earnings from Unconsolidated Entities
Equity earnings from our unconsolidated entities decreased of ($2,213), or (62.9%). The decrease was primarily due to an impairment loss taken on Pure Sunfarms’ inventory of ($1,042), as well as a lower Pure Sunfarms’ gross margin as a result of a lower selling price environment, as well as our share of VF Hemp’s third quarter losses of ($137). For information regarding the results of operation from our joint ventures, refer to “JV Cannabis Business” above and “Reconciliation of U.S. GAAP Results to Proportionate Results” below.
Net Income (Loss)
Net income (loss) for the three months ended September 30, 2020 and 2019 was $520 and ($704), respectively. The improvement was primarily due to an increase in our produce gross margin, partially offset by higher selling, general and administrative expenses and a decrease in equity earnings from Pure Sunfarms.
Adjusted EBITDA
Adjusted EBITDA for the three months ended September 30, 2020 increased 58.1% to $4,556 from $2,881 for the three months ended September 30, 2019 due primarily to a decrease in losses from consolidated entities of $3,437, offset by a decrease in equity earnings from our joint ventures. See the reconciliation of Adjusted EBITDA to net income in “Non-GAAP Measures - Reconciliation of Net Earnings to Adjusted EBITDA”.
Nine months ended September 30, 2020 compared to the nine months ended September 30, 2019.
Sales
Produce sales for the nine months ended September 30, 2020 increased $11,210, or 10.1%, to $122,722 compared to $111,512 for the nine months ended September 30, 2019. The increase in produce sales was primarily due to higher selling prices for tomatoes and a higher volume of supply partner produce during the nine months ended September 30, 2020 compared to the same prior year period.
Village Farms’ greenhouse production revenues were consistent with the prior year period even though production volume decreased due to the transition of the Delta 2 facility to Pure Sunfarms and a year over year decline in the overall production generated from our Texas facilities. The decrease in production volume was offset by an increase of 32% in the average selling price of Village Farms’ own production. The increase in selling prices for the commodity items was primarily due to a market supply shortage, largely stemming from changes in consumer buying habits affected by COVID-19. Pepper prices increased 19% and pepper pounds sold increased 37% when compared to the same prior year period. Cucumber prices increased 1% and cucumber pieces sold decreased (13%) for the nine months ended September 30, 2020 as compared to the same prior year period.
A summary of sales by product group in our greenhouse produce business, follows:
| Percent of Sales by Product Group | For the nine months ended September 30, 2020 | 2019 |
|---|---|---|
| Tomatoes | 90% | 85% |
| Peppers | 6% | 6% |
| Cucumbers | 4% | 9% |
| 100% | 100% |
Cost of Sales
Cost of sales for the nine months ended September 30, 2020 decreased ($1,609), or (1.4%), to $112,809 from $114,418 for the nine months ended September 30, 2019. This decrease is primarily due to the transition of our Delta 2 facility to Pure Sunfarms and lower production costs at our Texas facilities, offset by an increase in supply partner purchases.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the nine months ended September 30, 2020 increased $777, or 6.5%, to $12,676 from $11,899 for the nine months ended September 30, 2019. The increase was primarily related to an increase in legal and regulatory expenses related to incremental public company filings, the Pure Sunfarms acquisition and the first quarter Settlement Agreement, and an increase in employee compensation, which in turn were offset by reductions in accounting fees and travel expenses.
Share-based Compensation
Share-based compensation expense for the nine months ended September 30, 2020 decreased ($1,334), or (50.1%), to $1,329 from $2,663 for the nine months ended September 30, 2019. The decrease in share-based compensation expense was primarily due to the vesting of performance shares earned related to developments in Pure Sunfarms in 2019.
Interest Expense
Interest expense for the nine months ended September 30, 2020 decreased ($745), or (36.9%), to $1,273 from $2,018 for the nine months ended September 30, 2019. The decrease was due to lower interest rates as well as lower debt balances.
Interest Income
Interest income for the nine months ended September 30, 2020 and 2019 was $577 and $651, respectively. During 2020 we stopped accruing interest income for the VFH Grid Loan.
(Loss) Gain on Disposal of Assets
We recognized a loss on disposal of assets of ($6) for the nine months ended September 30, 2020 compared to a gain of $13,558 in the prior year period. The 2019 gain was due to the contribution of Delta 2 assets to Pure Sunfarms in March 2019. The gain represents the difference between our book value of the assets contributed and the CA$25,000 fair market value of stock received in Pure Sunfarms.
Income Tax Recovery (Provision)
For the nine months ended September 30, 2020, we recorded an income tax recovery of $607 compared to $114 for the nine months ended September 30, 2019. In 2020, we experienced a significant increase in its produce gross margin compared to the prior year period, along with a gain of $4,681 on the Settlement Agreement with Emerald. During 2019, we had a $13,558 gain on disposal of assets arising from the contribution of our Delta 2 assets to Pure Sunfarms. Pure Sunfarms and VF Hemp are both reported post-tax and therefore do not factor into our tax calculation.
Equity Earnings from Unconsolidated Entities
Equity earnings from our unconsolidated entities decreased ($9,230) or (65.4%) to $4,885 for the nine months ended September 30, 2020, from $14,115 for the same prior year period. The decrease was primarily due to a decrease in earnings from Pure Sunfarms’ of ($8,678), caused by an increase in the sales of lower margin large format products sold through the provincial (retail) boards and an overall decrease in the wholesale market in 2020 as compared to elevated pricing in the wholesale channel in 2019. In addition, Pure Sunfarms’ net income for the nine months ended September 30, 2020 includes a $4,348 gain resulting from the Settlement Agreement, of which $2,496 was our share. For information regarding the results of operations from our joint ventures, refer to “JV Cannabis Business” above and “Reconciliation of U.S. GAAP Results to Proportionate Results” below.
Net Income (Loss)
Net income (loss) for the nine months ended September 30, 2020 and 2019 was $4,591 and $9,509, respectively. The decrease was primarily the result of a decline in our equity earnings from unconsolidated entities of ($9,230) and, a $13,588 gain on disposal recorded during the nine months ended September 30, 2019, offset by an increase in our gross margin of $12,819 and a gain on settlement of $4,681 recognized during the nine months ended September 30, 2020.
Adjusted EBITDA
Adjusted EBITDA for the nine months ended September 30, 2020 decreased ($405), or (4.9%), to $7,921 from $8,326 for the nine months ended September 30, 2019 due primarily to the decrease in net income from joint ventures and the add back of the gains related to the Settlement Agreement, offset by the add back of the contribution of Delta 2 assets during the nine months ended September 30, 2019. See the reconciliation of Adjusted EBITDA to net income in “Non-GAAP Measures - Reconciliation of Net Earnings to Adjusted EBITDA”.
Liquidity and Capital Resources
Capital Resources
At September 30, 2020, we had $54,666 in cash and $70,048 of working capital. We expect to provide or obtain adequate financing to maintain and improve our property, plant and equipment, to fund working capital produce needs and invest in Pure Sunfarms for the next twelve months from cash flows from operations, and, as needed, from additional borrowings under the Credit Facilities (as defined below) or additional equity or debt financing.
| Maximum | Outstanding September 30, 2020 | |
|---|---|---|
| Operating loan | CA$ 13,000 | $3,000 |
| Term loan | $29,182 | $29,182 |
| VFCE loan | CA$ 1,210 | CA$ 1,210 |
At September 30, 2020 we had a term loan financing agreement with a Canadian creditor (“FCC Loan”). The non-revolving variable rate term loan had a maturity date of April 1, 2025 and a balance of $29,182 as of September 30, 2020. The outstanding balance is repayable by way of monthly installments of principal and interest, with the balance and any accrued interest to be paid in full on April 1, 2025. As of September 30, 2020, and December 31, 2019, borrowings under the FCC Loan were subject to an interest rate of 4.388% and 6.391%, respectively.
We are also party to a variable rate line of credit agreement with Bank of Montreal (“BMO”) that has a maturity date of May 31, 2021 (the “Operating Loan” and together with the FCC Loan, the “Credit Facilities”). The Operating Loan is subject to margin requirements stipulated by the bank based on produce sales. As at September 30, 2020 and 2019 there was $3,000 and $2,000, respectively, drawn on the Operating Loan, which is available to a maximum of CA$13,000, less outstanding letters of credit of US$150 and CA$38.
Our subsidiary VFCE has a loan agreement with a Canadian Chartered Bank that includes a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023 at a fixed interest rate of 4.98%. As of September 30, 2020, and December 31, 2019, the balance was CA$1,210 (US$830) and CA$1,526 (US$1,066), respectively. The loan agreement also includes an uncommitted, non-revolving credit facility for up to CA$300 to cover letters of guarantee issued by the bank on behalf of the Company, with a maximum term of 365 days, renewable annually.
As security for the FCC Loan, the Company has provided promissory notes, a first mortgage on the VFF-owned greenhouse properties (excluding the Delta 3 and Delta 2 greenhouse facilities) and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as of September 30, 2020 and December 31, 2019 was $215,581 and $155,548, respectively.
As security for the Operating Loan, the Company has provided promissory notes and a first priority security interest over its accounts receivable and inventory. In addition, the Company has granted full recourse guarantees and security therein. The carrying value of the assets pledged as collateral as of September 30, 2020 and December 31, 2019 was $25,799 and $24,915, respectively.
Our borrowings are subject to certain positive and negative covenants, including debt ratios, and we are required to maintain certain minimum working capital. In December 2019, we received a waiver for our annual debt service coverage and debt to EBITDA covenants under its FCC Loan. As of September 30, 2020, the Company was in compliance with all of its other Credit Facility covenants under its Credit Facilities.
Accrued interest payable on the Credit Facilities and loans as of September 30, 2020 and December 31, 2019 was $29 and $162, respectively. These amounts are included in accrued liabilities in the unaudited Condensed Consolidated Interim Statements of Financial Position.
In 2019, Pure Sunfarms entered into a credit agreement with BMO, as agent and lead lender, and Farm Credit Canada, as lender, in respect of a CA$20,000 secured non-revolver term loan (the “PSF Credit Facility”). In June 2020, Pure Sunfarms expanded the PSF Credit Facility with its existing lenders, and the addition of the Canadian Imperial Bank of Commerce, to CA$59.0 million, including accordion provisions of up to CA$22.5 million. As of September 30, 2020, the outstanding amount on the loan was CA$35.0 million.
The PSF Credit Facility, which matures on February 7, 2022, is secured by the Delta 2 and 3 greenhouse facilities and contains customary financial and restrictive covenants. The Company is not a party to the PSF Credit Facility but has guaranteed up to CA$10.0 million in connection with the PSF Credit Facility. On November 2, 2020, in conjunction with the closing of the acquisition of the remaining shares of Pure Sunfarms, the Company increased its guarantee to a total of CA$20 million in connection with the Pure Sunfarms Credit Facility.
We closed equity offerings on October 22, 2019, March 24, 2020 and September 10, 2020. The October 22, 2019 public offering raised net proceeds of CA$26,934 through the issuance of 3,059,000 Common Shares at a price of CA$9.40 per Common Share. The March 24, 2020 public offering raised net proceeds of CA$10,711 through the issuance of 3,593,750 Common Shares at a price of CA$3.20 per Common Share. The Registered Direct Offering, which closed on September 10, 2020, raised net proceeds of approximately US$46,800 (after placement agent fees, but before estimated offering expenses) through the issuance of 9,396,226 Units at a public offering price of US$5.30 per Unit. Each Unit that was sold consists of one Common Share and one-half of a Warrant at an exercise price of US$5.80. The Warrants will be exercisable beginning on March 10, 2021 and will expire on September 10, 2025. For more information, see “Executive Overview—Registered Direct Offering” above.
After quarter end, on November 2, 2020, in connection with the consummation of the Pure Sunfarms Transaction, we entered into the Promissory Note with Emerald, in the amount of C$19.9 million (US$14.5 million), payable to Emerald on May 2, 2021, or six months from the consummation of the Pure Sunfarms Transaction. Interest on the principal amount owed under the Promissory Note will accrue at the lower of (i) the maximum non-usurious rate of interest under applicable law or (ii) 12% per annum. In order to secure our obligations under the Promissory Note, on November 2, 2020, we entered into the Share Pledge Agreement with Emerald and Computershare Trust Company of Canada, as collateral agent, in order to pledge 9,239,625 common shares of Pure Sunfarms to Emerald as collateral for the amounts owed by us under the Promissory Note.
Summary of Cash Flows
(in Thousands)
| For the nine months ended September 30, 2020 | 2019 | |
|---|---|---|
| Cash beginning of period | $11,989 | $11,920 |
| Net cash flow provided by (used in): | ||
| Operating activities | 4,014 | (7,887) |
| Investing activities | (14,148) | (11,090) |
| Financing activities | 52,812 | 13,783 |
| Net cash increase (decrease) for the period | 42,678 | (5,194) |
| Effect of exchange rate changes on cash | (1) | — |
| Cash, end of the period | $54,666 | $6,726 |
Operating Activities
For the nine months ended September 30, 2020 and 2019, cash flows used in operating activities before changes in non-cash working capital totaled ($924) and ($12,036), respectively. The improvement is primarily attributable to a $12,819 increase in year over year gross margin which contributed to an increase in our net income, adjusted for non-cash expenses.
Investing Activities
For the nine months ended September 30, 2020 and 2019, cash flows used in investing activities were ($14,148) and ($11,090), respectively. The 2020 investing activities consist primarily of $11,713 invested in Pure Sunfarms for its Delta 2 facility conversion and $1,226 invested in our two minority cannabis investments, DCG and Altum. In 2019, our investing activities were focused on U.S. Hemp with loans totaling $9,133 to our U.S. joint ventures.
Financing Activities
For the nine months ended September 30, 2020 and 2019, cash flows provided by financing activities were $52,812 and $13,783, respectively. The year over year increase is primarily due to a $49,800 unit issuance in September 2020, predominately used to finance the acquisition of remaining shares of Pure Sunfarms.
Contractual Obligations and Commitments
During the nine months ended September 30, 2020, we made equity contributions to Pure Sunfarms totaling CA$16,000 (US$11,713).
Information regarding our contractual obligations as of September 30, 2020 is set forth in the table below:
| Financial liabilities | Total | 1 year | 2-3 years | 4-5 years | More than 5 years |
|---|---|---|---|---|---|
| Long-term debt | $31,436 | $2,310 | $4,566 | $3,935 | $20,625 |
| Line of credit | 3,000 | 3,000 | — | — | — |
| Trade payables | 9,667 | 9,667 | — | — | — |
| Accrued liabilities | 6,676 | 6,676 | — | — | — |
| Operating lease liabilities | 4,176 | 1,076 | 1,851 | 1,143 | 106 |
| Capital lease liabilities | 46 | 34 | 12 | ||
| Total | $55,001 | $22,763 | $6,429 | $5,078 | $20,731 |
After September 30, 2020, we entered into the Promissory Note in the amount of C$19.9 million (US$14.5 million), payable to Emerald on May 2, 2021, or six months from the consummation of the Purchase Agreement for the Pure Sunfarms Transaction.
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements.
Non-GAAP Measures
References in this report to “Adjusted EBITDA” are to earnings (including the equity in earnings of the Pure Sunfarms) before interest, taxes, depreciation and amortization (“EBITDA”), as further adjusted to exclude foreign currency exchange gains and losses on translation of long-term debt, unrealized gains on the changes in the value of derivative instruments, stock compensation, and gains and losses on asset sales, and adjusts for the difference in accounting treatment of Pure Sunfarms, which we believe is necessary to reflect the true economic value of our interest in Pure Sunfarms. Adjusted EBITDA is a cash flow measure that is not recognized under GAAP and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that Adjusted EBITDA should not be construed as an alternative to net income or loss determined in accordance with GAAP as an indicator of our performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that Adjusted EBITDA is an important measure in evaluating the historical performance of the Company.
We also present Adjusted EBITDA, earnings per share and diluted earnings per share on a proportionate segment basis. Each of the components of Adjusted EBITDA, on a proportionate segment basis (which include our proportionate share of Pure Sunfarms and VF Hemp operations), are presented in the table Reconciliation of U.S. GAAP Results to Proportionate Results below. We believe that the ability of investors to assess our overall performance may be improved by the disclosure of proportionate segment Adjusted EBITDA, earnings per share and diluted earnings per share, given that our joint ventures represent a significant percentage of our net income.
Reconciliation of Net Income to Adjusted EBITDA
The following table reflects a reconciliation of net income to Adjusted EBITDA, as presented by the Company:
| For the three months ended September 30, 2020 | 2019 | For the nine months ended September 30, 2020 | 2019 | |
|---|---|---|---|---|
| Net (loss) income | $520 | $(704) | $4,591 | $9,509 |
| Add: | ||||
| Amortization | 1,518 | 2,360 | 4,540 | 5,587 |
| Foreign currency exchange loss (gain) | 484 | 183 | 880 | (338) |
| Interest expense, net | 198 | 351 | 696 | 1,367 |
| Provision for (recovery of) income taxes | 336 | (1,266) | (607) | (114) |
| Stock based compensation | 472 | 666 | 1,329 | 2,663 |
| Interest expense for JVs | 240 | 276 | 636 | 506 |
| Amortization for JVs | 598 | 414 | 1,276 | 1,125 |
| Foreign currency exchange loss (gain) for JVs | 33 | (8) | 118 | (21) |
| Provision for income taxes from JVs | 245 | 1,355 | 1,736 | 5,572 |
| Gain on settlement agreement | — | — | (4,681) | — |
| Gain on settlement of net liabilities from JV | — | — | (2,496) | — |
| Gain on disposal of assets | (88) | 8 | (97) | (13,558) |
| Adjustment to reflect true economic value for Pure Sunfarms(1) | — | (754) | — | (3,972) |
| Adjusted EBITDA | $4,556 | $2,881 | $7,921 | $8,326 |
| Adjusted EBITDA for JVs (See table below) | $2,333 | $4,826 | $6,050 | $17,346 |
| Adjusted EBITDA excluding JVs(produce) | $2,223 | $(1,945) | $1,871 | $(9,020) |
| Breakout of JV Adjusted EBITDA | For the three months ended September 30, 2020 | 2019 | For the nine months ended September 30, 2020 | 2019 |
|---|---|---|---|---|
| Pure Sunfarms Adjusted EBITDA | $2,511 | $5,035 | $6,365 | $17,710 |
| VFH Adjusted EBITDA | (178) | (209) | (315) | (364) |
| Total JV Adjusted EBITDA | $2,333 | $4,826 | $6,050 | $17,346 |
27
(1) The GAAP treatment of our equity earning of Pure Sunfarms is different than under International Financial Reporting Standards (“IFRS”). Under GAAP the Emerald shares held in escrow are not considered issued until paid for pursuant to the GAAP concept of ‘hypothetical liquidation’. As a result, our ownership percentage for the three and nine months ended September 30, 2019 was 61.4% and 60.8%, respectively, compared to our economic interest under IFRS of 50% for the same periods.
Reconciliation of U.S. GAAP Results to Proportionate Results
The following tables are a reconciliation of the GAAP results to the proportionate results (which include our proportionate share of Pure Sunfarms and VF Hemp operations):
| For the Three months ended September 30, 2020 Produce | Pure Sunfarms (1) | Hemp (1) | Total | |
|---|---|---|---|---|
| Sales | $43,037 | $10,007 | $— | $53,044 |
| Cost of sales | (37,418) | (6,547) | — | (43,965) |
| Selling, general and administrative expenses | (4,942) | (1,436) | (213) | (6,591) |
| Stock compensation expense | (472) | — | — | (472) |
| Gain on disposal of assets | — | — | 89 | 89 |
| Other expense, net | (655) | (336) | (13) | (1,004) |
| Provision for income taxes | (336) | (245) | — | (581) |
| Net (loss) income | $(786) | $1,443 | $(137) | 520 |
| Adjusted EBITDA (2) | $2,223 | $2,511 | $(178) | $4,556 |
| (Loss) income per share – basic | $(0.01) | $0.02 | $(0.00) | $0.01 |
| (Loss) income per share – diluted | $(0.01) | $0.02 | $(0.00) | $0.01 |
| For the three months ended September 30, 2019 Produce | Pure Sunfarms (1) | Hemp (1) | Total | |
|---|---|---|---|---|
| Sales | $38,293 | $10,217 | $— | $48,510 |
| Cost of sales | (38,904) | (3,211) | — | (42,115) |
| Selling, general and administrative expenses | (3,739) | (1,635) | (229) | (5,603) |
| Stock compensation expense | (666) | — | — | (666) |
| Loss on disposal of assets | (8) | — | — | (8) |
| Other expense, net | (465) | (162) | — | (627) |
| Recovery of (provision for) income taxes | 1,266 | (1,461) | — | (195) |
| Net (loss) income | $(4,223) | $3,748 | $(229) | $(704) |
| Adjusted EBITDA (2) | $(1,945) | $5,035 | $(209) | $2,881 |
| (Loss) income per share – basic | $(0.09) | $0.08 | $(0.00) | $(0.01) |
| (Loss) income per share – diluted | $(0.09) | $0.08 | $(0.00) | $(0.01) |
28
| For the nine months ended September 30, 2020 Produce | Pure Sunfarms (1) | Hemp (1) | Total | |
|---|---|---|---|---|
| Sales | $122,722 | $22,958 | $98 | $145,778 |
| Cost of sales | (112,809) | (13,782) | (120) | (126,711) |
| Selling, general and administrative expenses | (12,676) | (3,870) | (500) | (17,046) |
| Stock compensation expense | (1,329) | — | — | (1,329) |
| Gain on settlement agreement | 4,681 | — | — | 4,681 |
| Gain on settlement of net liabilities | — | 2,496 | — | 2,496 |
| Loss on disposal of assets | (6) | 5 | 99 | 98 |
| Other expense, net | (1,484) | (634) | (129) | (2,247) |
| Recovery of (provision for) income taxes | 607 | (1,736) | — | (1,129) |
| Net (loss) income | $(294) | $5,437 | $(552) | $4,591 |
| Adjusted EBITDA (2) | $1,871 | $6,365 | $(315) | $7,921 |
| (Loss) income per share – basic | $(0.00) | $0.09 | $(0.01) | $0.08 |
| (Loss) income per share – diluted | $(0.00) | $0.09 | $(0.01) | $0.08 |
| For the nine months ended September 30, 2019 Produce | Pure Sunfarms (1) | Hemp (1) | Total | |
|---|---|---|---|---|
| Sales | $111,512 | $32,011 | $— | $143,523 |
| Cost of sales | (114,418) | (8,137) | — | (122,555) |
| Selling, general and administrative expenses | (11,899) | (3,334) | (378) | (15,611) |
| Stock compensation expense | (2,663) | — | — | (2,663) |
| Gain on disposal of assets | 13,558 | — | — | 13,558 |
| Other expense, net | (810) | (322) | — | (1,132) |
| Recovery of (provision for) income taxes | 114 | (5,725) | — | (5,611) |
| Net (loss) income | $(4,606) | $14,493 | $(378) | $9,509 |
| Adjusted EBITDA (2) | $(9,020) | $17,710 | $(364) | $8,326 |
| (Loss) income per share – basic | $(0.09) | $0.30 | $(0.01) | $0.20 |
| (Loss) income per share – diluted | $(0.09) | $0.29 | $(0.01) | $0.19 |
Notes:
(1) The adjusted consolidated financial results have been adjusted to include our share of sales and expenses from Pure Sunfarms and Hemp on a proportionate accounting basis, on which management bases its operating decisions and performance evaluation. GAAP does not allow for the inclusion of the joint ventures on a proportionate basis. These results include additional non-GAAP measures such as Adjusted EBITDA.
The adjusted results are not generally accepted measures of financial performance under GAAP. Our method of calculating these financial performance measures may differ from other companies and accordingly, they may not be comparable to measures used by other companies.
(2) Adjusted EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. See “Non-GAAP Measures”. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company. Consolidated Adjusted EBITDA includes our majority non-controlling interest Pure Sunfarms and our 65% interest in VF Hemp.
New Accounting Pronouncements Not Yet Adopted
In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” ASU 2019-12 simplifies the accounting for income taxes by removing exceptions within the general principles of Topic 740 regarding the calculation of deferred tax liabilities, the incremental approach for intraperiod tax allocation, and calculating income taxes in an interim period. In addition, the ASU adds clarifications to the accounting for franchise tax (or similar tax). which is partially based on income, evaluating tax basis of goodwill recognized from a business combination, and reflecting the effect of any enacted changes in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. The ASU is effective for fiscal years beginning after December 15, 2020 and will be applied either retrospectively or prospectively based upon the applicable amendments. Early adoption is permitted. We are currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.
Critical Accounting Estimates and Judgments
Our discussion and analysis of our financial condition and results of operations are based upon our Unaudited Condensed Consolidated Interim Financial Statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, sales and expenses and related disclosure of contingent assets and liabilities.
We believe that the estimates, assumptions and judgments involved in the accounting policies described in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our most recent Annual Report on Form 10-K have the greatest potential impact on our financial statements, so we consider these to be our critical accounting policies. Actual results could differ from the estimates we use in applying our critical accounting policies. We are not currently aware of any reasonably likely events or circumstances that would result in materially different amounts being reported.
Market risk
As filed, 2,242 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Interest Rate Risk
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt, for which the interest rates charged fluctuate based on the 90-day LIBOR rate. If interest rates had been 50 basis points higher (lower), the net income for the nine months ended September 30, 2020 and 2019 would have been higher (lower) by $117 and $128, respectively. This represents $117 and $128 in increased (decreased) interest expense for the periods ended September 30, 2020 and 2019, respectively.
While we cannot predict our ability to refinance existing debt or the significance of the impact that interest rate movements will have on our existing debt, management evaluates our financial position on an ongoing basis.
Foreign Exchange Risk
As of September 30, 2020, and 2019, the Canadian/U.S. foreign exchange rate was C$1.00 = US$0.7482 and C$1.00 = US$0.7552, respectively. Assuming that all other variables remain constant, an increase of $0.10 in the Canadian dollar would have the following impact on the ending balances of certain statements of financial position items at September 30, 2020 and September 30, 2019 with the net foreign exchange gain or loss directly impacting net income (loss).
| Financial assets | September 30, 2020 | September 30, 2019 |
|---|---|---|
| Cash and cash equivalents | $6,298 | $189 |
| Trade receivables | 340 | 367 |
| JV notes receivable | 1,464 | 1,387 |
| Financial liabilities | ||
| Trade payables and accrued liabilities | (454) | (658) |
| Loan payable | (121) | (163) |
| Net foreign exchange gain (loss) | $7,527 | $1,122 |
Our exposure to foreign exchange risk and the impact of foreign exchange rates are monitored by the Company’s management but generally the Company tries to match its sales (trade receivables) and vendor payments (trade payables) such that the net impact is not material.
Other than the interest rate risk and foreign exchange risk discussed above, there have been no material changes to our market risks from those disclosed in Part II, Item 7A of our Annual Report on Form 10-K.
Controls and procedures
As filed, 1,968 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified by the U.S. Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Principal Financial and Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure.
The Company’s Chief Executive Officer and Principal Financial and Accounting Officer evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Exchange Act of 1934, as amended) as of the end of the period covered by this Quarterly Report. Based upon that evaluation, the Chief Executive Officer and the Principal Financial and Accounting Officer concluded that, as of the end of the period covered by this Quarterly Report, the Company’s disclosure controls and procedures are effective.
Changes in Internal Control over Financial Reporting
The Company’s management, including the Chief Executive Officer and Principal Financial and Accounting Officer, has reviewed the Company’s internal control over financial reporting. There were no changes in the Company’s internal control over financial reporting during the quarter ended September 30, 2020 that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 1,052 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our business, operations, and financial condition are subject to various risks and uncertainties. The risk factors described in Part I, Item 1A, “Risk Factors” contained in our Annual Report on Form 10K for the year ended December 31, 2019, as filed with the SEC on April 1, 2020, should be carefully considered, together with the other information contained or incorporated by reference in this Quarterly Report on Form 10-Q and in our other filings filed with the SEC in connection with evaluating us, our business, and the forward-looking statements contained in this Quarterly Report on Form 10-Q. During the quarter ended September 30, 2020, there have been no material changes from the risk factors previously disclosed under Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K, for the year ended December 31, 2019, except as described in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Recent developments relating to the outbreak of the Coronavirus pandemic (“COVID-19”)”.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-01 to 2020-09-30 | $43.0m | us-gaap:Revenues |
| Revenue | 9 months2020-01-01 to 2020-09-30 | $122.7m | us-gaap:Revenues |
| Cost of revenue | 3 months2020-07-01 to 2020-09-30 | $37.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-01-01 to 2020-09-30 | $112.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-07-01 to 2020-09-30 | $5.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-01-01 to 2020-09-30 | $9.9m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2020-07-01 to 2020-09-30 | $4.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-01-01 to 2020-09-30 | $12.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2020-07-01 to 2020-09-30 | $299.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2020-01-01 to 2020-09-30 | $1.3m | us-gaap:InterestExpense |
| Income tax | 3 months2020-07-01 to 2020-09-30 | $336.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-09-30 | −$607.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-07-01 to 2020-09-30 | $520.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-09-30 | $4.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-07-01 to 2020-09-30 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-01-01 to 2020-09-30 | $0.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-07-01 to 2020-09-30 | $0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-01-01 to 2020-09-30 | $0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-07-01 to 2020-09-30 | 60,440,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-01-01 to 2020-09-30 | 57,778,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-01-01 to 2020-09-30 | $4.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-01-01 to 2020-09-30 | $1.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-09-30 | $54.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-09-30 | $93.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-09-30 | $243.8m | us-gaap:Assets |
| Current liabilities | At period end2020-09-30 | $23.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-09-30 | $57.3m | us-gaap:Liabilities |
| Long-term debt | At period end2020-09-30 | $27.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-09-30 | $2.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-09-30 | $186.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-20-053721. Last ingested by Listed: Nov 9, 2026, 17:26 ET. Listed shows no prices and gives no investment advice.